JPRN-UMIN000049985已完成Unknown
Proposed cut-off CA19-9 values for detection of pancreatic cancer in patients with poorly glycemic controlled diabetes: a real-world study - Proposed cut-off CA19-9 values for detection of pancreatic cancer in patients with poorly glycemic controlled diabetes: a real-world study
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 1,060
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who refuse participating in research in response to opt-out notification Patients with malignant tumors requiring treatment currently
研究者
相似试验
尚未招募
不适用
Clinical Value of CA 19-9 with Reference to the Lewis Blood Group Status for Prediction of Benign and Malignant Obstructive JaundiceObstructive jaundiceCA 19NjLewis blood groupTCTR20160927002The Thailand Research Fund (TRF)129
尚未招募
Unknown
Correlation of CA19-9 blood marker and ability to cure pancreatic cancer with surgeryCTRI/2024/07/071305Dr Shrey Khanna
尚未招募
不适用
Tumor Marker CA-19-9, CEA,CA125, CA242 for early diagnosis and predicting prognosis in gall bladder cancer patientCTRI/2019/03/018064Director
招募中
不适用
The new risk scoring system for predicting epithelial ovarian malignancy: Risk of ovarian cancer score (ROCS)Adnexal massOvarian cancerAdnexal mass, Ovarian cancer, Predictive model, Risk scoringTCTR20231103007Srinakharinwirot University124
招募中
不适用
Defining the Diagnostic Value of High-Pitch CCTA and Dynamic CT Perfusion in patients with prior PCI for the Diagnosis of Myocardial Ischemia as Defined by Invasive Flow and Pressure Indices - The PACIFIC-III trialarteriosclerosisNL-OMON50843Vrije Universiteit Medisch Centrum140